Find your path to Laura
228 people in our graph share verified history with Laura — schools, employers, funds. One of them is your warm intro.
Antonio HerceunlockedLaura: together at Universitat de Lleida (2013–2015)
×6Laura: together at Universitat Autònoma de Barcelona
×3Laura: together at Wageningen University & Research
×2Laura: together at Ysios Capital
About
Laura Argelich helps identify and evaluate investment opportunities at Ysios Capital from scientific and business angles. Before joining the firm, she worked in the Stem Cells and Neurogenesis unit at Ospedale San Raffaele in Milan, where her research focused on direct reprogramming approaches and dopaminergic neurons in Parkinson's disease. She holds a master's degree in Biochemistry, Molecular Biology and Biomedicine from the Universitat Autònoma de Barcelona and a PhD in Molecular Medicine from the Università Vita-Salute San Raffaele.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Ysios CapitalAssociatecurrent2025 — presentBarcelona, Catalonia, Spain
- Ysios CapitalInvestment Analyst2023 — 2025Barcelona, Catalonia, Spain
- Ysios CapitalVC Fellow2023Barcelona, Catalonia, Spain
- Tagworks PharmaceuticalsBoard Observercurrent2024 — presentNijmegen, Gelderland, Netherlands
- Memo Therapeutics AGBoard Observercurrent2024 — presentSchlieren, Zurich, Switzerland
- AdcendoBoard Observer2024Copenhagen, Capital Region of Denmark, Denmark
- Università Vita-Salute San Raffaele MilanoPhD Student | Marie Skłodowska-Curie Early Stage Researcher2019 — 2023Greater Milan Metropolitan Area
- Università Vita-Salute San Raffaele MilanoResearch Fellow2019Milan, Lombardy, Italy
- Bellvitge Biomedical Research Institute - IDIBELLMaster Student Trainee2018
- Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré - IRBLLEIDAUndergraduate Research Internship2016 — 2017Greater Lerida Area
- Semmelweis Egyetem/ Semmelweis UniversityUndergraduate Summer Internship2016Hungary
Skills & more
Biotechnology4Molecular BiologyLaboratory Skills1TeamworkMicrosoft Office2
Languages Catalan · English · Italian · Spanish
From Laura's professional profile.
Investments
Board seats
AdcendoMemo TherapeuticsTagworks Pharmaceuticals
Per the firm's website.
Colleagues at Ysios Capital
Almudena Méndez
Associate at Ysios Capital
Antoni Ribas
Venture Partner at Ysios Capital
Arturo Urrios
Partner at Ysios Capital
Carlos Garcia-Echeverria
Venture Partner at Ysios Capital
Carlos Paya
Venture Partner at Ysios Capital
Catalina Cuchy
Executive Assistant at Ysios Capital
Cristina Garmendia
General Partner at Ysios Capital
David L. Lacey
Venture Partner at Ysios Capital
Frequently asked questions
- Who is Laura Argelich?
- Laura Argelich helps identify and evaluate investment opportunities at Ysios Capital from scientific and business angles. Before joining the firm, she worked in the Stem Cells and Neurogenesis unit at Ospedale San Raffaele in Milan, where her research focused on direct reprogramming approaches and dopaminergic neurons in Parkinson's disease. She holds a master's degree in Biochemistry, Molecular Biology and Biomedicine from the Universitat Autònoma de Barcelona and a PhD in Molecular Medicine from the Università Vita-Salute San Raffaele.
- Where does Laura Argelich work?
- Laura Argelich is Associate at Ysios Capital.
- What does Laura Argelich invest in?
- Laura Argelich invests in Biotech.
- What boards does Laura Argelich sit on?
- Laura Argelich holds tracked board seats at Adcendo, Memo Therapeutics, Tagworks Pharmaceuticals.
- Where did Laura Argelich go to school?
- Laura Argelich studied at Libera Università Vita-Salute San Raffaele (PhD in Molecular Medicine, Neuroscience and Experimental Neurology); Universitat Autònoma de Barcelona (Master's degree in Biochemistry, Molecular Biology and Biomedicine); Wageningen University & Research (Bachelor's degree, Biotechnology).
Same school
Also attended Libera Università Vita-Salute San Raffaele7
Maurizio FazioPrincipal at Atlas VentureMartina Lubrano di RiccoAssociate at Delin VenturesBianca BenattiJr. Analyst at XGEN VentureAlex LaterzaAdvisor at Exceptional VenturesJacopo TagliabuePresident at BauplanMattia PavoniChief Financial Officer at Bauplan
+ 1 more
Also attended Universitat Autònoma de Barcelona128
Eduard FeliuManaging Partner at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupNash Carey-EwendSenior Associate, Echo Health Advisors at Echo Health VenturesAgustina NietoLegal Counsel at Nauta CapitalIsabel JimenezPrincipal at Asabys PartnersDr. Benedikt BuchspiesPrincipal - Technology Research and Science at Planet A Ventures
+ 122 more
Also attended Wageningen University & Research51
Xavier MesnierPartner, Head of Frontiers in Health & Bio Investments at Verve VenturesThomas van den BoezemPartner at PeakBridge VCPavlos KalaitzoglouDirector of Research at Astanor VenturesMichel BriejerManaging Partner at Thuja CapitalMarcel ZijpSenior Investment Manager at Brightlands Venture PartnersAurelie NowackPrincipal at V-Bio Ventures
+ 45 more
Also attended Universitat de Lleida6
Shared employers
Also worked at Ysios Capital25
Josep Ll. SanfeliuCo-founder and managing partner at Asabys PartnersSylvain SachotPartner at Asabys PartnersIsabel JimenezPrincipal at Asabys PartnersJoël Jean-MairetManaging Partner at Ysios CapitalJulia SalaverríaManaging Partner at Ysios CapitalKaren WagnerManaging Partner at Ysios Capital
+ 19 more
Also worked at Tagworks Pharmaceuticals3
Also worked at Memo Therapeutics AG8
Thomas HarthPartner at Ysios CapitalMichael SidlerFounding Partner at redalpineHadrien BouchezPartner at Kurma PartnersAndreas WüpperManaging Director at Fresenius Medical Care VenturesButrint AliuAnalyst at Pureos BioventuresMichael HodgesEntrepreneur in Residence at Claris Ventures
+ 2 more
